$TEVA trading flat after announcing a Medicaid pricing deal with Trump administration. The pharma giant "committed" to cheaper drugs for Medicaid, but the deal isn't finalized yet. Stock barely moved, down just 0.04%.

The proposal includes matching developed-market prices and most-favored-nation pricing on future launches, plus an API reserve. They're calling it GENEROUS.

Market reaction? Complete nothingburger. Tape doesn't care.